You are here

obesity

Allergan wants to trim obesity treatment unit

The Deal

Sun, 02/10/13 - 11:51 am

Slow and steady can win the diet drug race: Vivus' launch of Belviq

Reuters

Fri, 02/8/13 - 11:17 am

EnteroMedics acknowledges mixed results for obesity device pivotal trial

FierceMedicalDevice

Thu, 02/7/13 - 09:19 pm

clinical trials

Allergan Seeks to Sell Lap-Band and Obesity Unit By June

Bloomberg

Tue, 02/5/13 - 06:12 pm

The Obesity Epidemic: EnteroMedics' New Treatment Approach

Seeking Alpha

Tue, 01/29/13 - 11:09 am

Arena Pharmaceuticals

Arena Must Wait For European Approval

Seeking Alpha

Sat, 01/19/13 - 12:05 pm

Arena Pharmaceutical

The Biggest Loser in the Obesity Drug Market

Motley Fool

Fri, 01/18/13 - 09:20 am

Arena Pharmaceuticals

Will Qsymia's Stellar Sales Growth Continue?

Motley Fool

Fri, 01/11/13 - 12:15 pm

Allergan Seeks Sale of Obesity Business by First Quarter

Bloomberg

Tue, 01/8/13 - 09:02 am

Vivus obesity pill prescriptions jump 68 percent, shares rise

Reuters

Mon, 01/7/13 - 10:39 am

And the Obesity Plot Thickens

Motley Fool

Wed, 01/2/13 - 11:58 am

Arena Pharmaceuticals

Takeda and Amylin terminate obesity compound co-development agreement

equities.com

Sat, 12/29/12 - 10:38 am

Key Dates For Arena And Orexigen Investors

Seeking Alpha

Wed, 12/26/12 - 09:34 pm

Arena Pharmaceuticals

Does Qsymia Have a Future After All?

Wall Street Cheat Street

Sat, 12/22/12 - 12:26 pm

Vivus Rises On Wider Coverage Of Qsymia

Seeking Alpha

Fri, 12/21/12 - 10:25 am

Orexigen: Is Contrave The Long-Term Winner In The Anti-Obesity Drug Wars?

Seeking Alpha

Mon, 12/17/12 - 01:22 pm

Vivus shares jump on strong growth in Qsymia prescriptions

Reuters

Mon, 12/17/12 - 01:21 pm

Investor Enthusiasm Wanes For Obesity Drug Companies

Seeking Alpha

Sun, 12/16/12 - 11:01 am

Arena Pharmaceuticals

The Looming EU Approval Makes Arena Pharmaceuticals Significantly Undervalued

Motley Fool

Sun, 12/16/12 - 10:18 am

Pages